Privileged structure-based quinazolinone natural product-templated libraries: identification of novel tubulin polymerization inhibitors.

A focused quinazolinone natural product-templated library was designed and synthesized. Compounds from this privileged structure-based library were identified as antimitotic agents acting through destabilization of tubulin polymerization. The results suggested that 2 could be a privileged substructure.

[1]  A. Al-Shamma,et al.  Antimicrobial agents from higher plants. Antimicrobial agents from Peganum harmala seeds. , 1981, Journal of natural products.

[2]  R. M. Desai,et al.  Vasicinone. A Bronchodilator Principle from Adhatoda Vasica Nees (N. O. Acanthaceae) , 1963 .

[3]  R. Desimone,et al.  Privileged structures: applications in drug discovery. , 2004, Combinatorial chemistry & high throughput screening.

[4]  W. Greenlee,et al.  A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor. , 1993, Journal of medicinal chemistry.

[5]  D. Dexter,et al.  Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. , 1990, Journal of medicinal chemistry.

[6]  S. Kuo,et al.  Antitumor agents. Part 204: synthesis and biological evaluation of substituted 2-aryl quinazolinones. , 2001, Bioorganic & medicinal chemistry letters.

[7]  D. Cherrak,et al.  High throughput HPLC/MS purification in support of drug discovery , 2004 .

[8]  Mimi Shirasu-Hiza,et al.  Dynamics of the mitotic spindle--potential therapeutic targets. , 2003, Progress in cell cycle research.

[9]  P. Molina,et al.  Inhibition of leukocyte functions by the alkaloid isaindigotone from Isatis indigotica and some new synthetic derivatives. , 2001, Journal of natural products.

[10]  A. Ganesan,et al.  Total synthesis of the fumiquinazoline alkaloids: solution-phase studies. , 2000, The Journal of organic chemistry.

[11]  S. Ng,et al.  A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. , 2001, Cancer research.

[12]  J. Fremlin.  Sub-surface Temperatures on the Moon , 1959, Nature.

[13]  M. Jordan,et al.  Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.

[14]  W. Goetzinger,et al.  High-throughput techniques for compound characterization and purification. , 2001, Current opinion in drug discovery & development.

[15]  T. Nomura,et al.  TWO NEW PYRROLOQUINAZOLINOQUINOLINE ALKALOIDS FROM PEGANUM NIGELLASTRUM , 1997 .

[16]  Libing Yu,et al.  Three-component one-pot total syntheses of glyantrypine, fumiquinazoline F, and fiscalin B promoted by microwave irradiation. , 2005, The Journal of organic chemistry.

[17]  E. Hamel,et al.  Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones. , 2004, European journal of medicinal chemistry.

[18]  K. Wood,et al.  Past and future of the mitotic spindle as an oncology target. , 2001, Current opinion in pharmacology.

[19]  P. Schultz,et al.  Identification of a novel protein regulating microtubule stability through a chemical approach. , 2004, Chemistry & biology.

[20]  S. Koul,et al.  Novel nor-harmal alkaloid from Adhatoda vasica , 1980 .

[21]  Stefan Dimitrov,et al.  Histone H3 phosphorylation and cell division , 2001, Oncogene.

[22]  Christopher J. Wilson,et al.  Novel one-pot total syntheses of deoxyvasicinone, mackinazolinone, isaindigotone, and their derivatives promoted by microwave irradiation. , 2005, Organic Letters.

[23]  S. Hecht,et al.  Luotonin A. A naturally occurring human DNA topoisomerase I poison. , 2003, Journal of the American Chemical Society.

[24]  Douglas A. Horton,et al.  The combinatorial synthesis of bicyclic privileged structures or privileged substructures. , 2003, Chemical reviews.

[25]  Libing Yu,et al.  Microwave-assisted one-pot synthesis of 2,3-disubstituted 3 H-quinazolin-4-ones , 2005 .

[26]  D. Mehta,et al.  A Bronchodilator Alkaloid (Vasicinone) from Adhatoda vasica Nees , 1959, Nature.

[27]  B. E. Evans,et al.  Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of Medicinal Chemistry.